PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29930537-12	2018	Cholecalciferol prevented prednisolone-elicited disturbances of the RANKL/RANK/OPG, which correlated with improved bioavailability and vitamin D signaling through VDR.	Cholecalciferol	0-15	TNF superfamily member 11	Rattus norvegicus	68-73	
29930537-14	2018	Our findings suggest that prednisolone-induced abnormalities in GR and RANKL/RANK/OPG signaling pathways are associated with the impairments of vitamin D auto/paracrine system in BM cells and can be ameliorated by cholecalciferol supplementation.	Cholecalciferol	214-229	TNF superfamily member 11	Rattus norvegicus	71-76	
34657267-3	2022	We hypothesized that vitamin D3 supplementation affects OPG and RANKL activity in the aorta.	Cholecalciferol	21-31	TNF superfamily member 11	Rattus norvegicus	64-69	
34657267-10	2022	CONCLUSIONS: It is concluded that vitamin D3 supplementation has a modulatory effect on OPG/RANKL activity in the vessel wall by ameliorating endothelial damage in diabetes.	Cholecalciferol	34-44	TNF superfamily member 11	Rattus norvegicus	92-97	
25762594-7	2015	Vitamin D3 significantly promoted RANKL expression in ABCs and OPG in DPCs.	Cholecalciferol	0-10	TNF superfamily member 11	Rattus norvegicus	34-39